Relation between DNA damage measured by comet assay and OGG1 Ser326Cys polymorphism in antineoplastic drugs biomonitoring
Antineoplastic drugs are hazardous chemical agents used mostly in the treatment of patients with cancer, however health professionals that handle and administer these drugs can become exposed and develop DNA damage. Comet assay is a standard method for assessing DNA damage in human biomonitoring and...
Main Authors: | Carina Ladeira, Susana Viegas, Mário Pádua, Elisabete Carolino, Manuel C. Gomes, Miguel Brito |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2015-09-01
|
Series: | AIMS Molecular Science |
Subjects: | |
Online Access: | http://www.aimspress.com/article/10.3934/genet.2015.3.204 |
Similar Items
-
Relation between DNA damage measured by comet assay and <em>OGG1 </em>Ser326Cys polymorphism in antineoplastic drugs biomonitoring
by: Carina Ladeira, et al.
Published: (2015-09-01) -
Comet assay as a human biomonitoring tool: application in occupational exposure to antineoplastic drugs
by: Carina Ladeira, et al.
Published: (2015-05-01) -
Meta Analysis of Association between Ser326Cys Polymorphism of hOGG1 Gene and Risk of Lung Cancer
by: Qian QIAN, et al.
Published: (2011-03-01) -
Lung Cancer Susceptibility and hOGG1 Ser326Cys Polymorphism: A Meta-Analysis
by: Chikako Kiyohara, et al.
Published: (2010-10-01) -
B-Comet Assay (Comet Assay on Buccal Cells) for the Evaluation of Primary DNA Damage in Human Biomonitoring Studies
by: Carla Russo, et al.
Published: (2020-12-01)